Expression of insulin‐like growth factor‐1 receptor in keloid and hypertrophic scar
Clinical and Experimental Dermatology2014Vol. 39(7), pp. 822–828
Citations Over TimeTop 10% of 2014 papers
Abstract
IGF-IR may be involved in the pathogenesis of keloid and HS. Given that IGF-IR are predominantly expressed on dermal fibroblasts, targeting of IGF-IR in fibroblasts may be of benefit to prevent scarring.
Related Papers
- Content Changes of Type I/III Collagen in Tissues of Hypertrophic Scar and Keloid and Its Clinical Significance(2004)
- → Profile of Working-Age Patients with Keloid and Hypertrophic Scar at Dr. Soetomo General Hospital Surabaya in 2014-2017(2021)1 cited
- Experimental Study of Difference between Keloid and Hypertrophic Scar(2000)
- → [Advances in the research of relationship between CD26 and hypertrophic scar and keloid].(2018)
- → Alternative strategy to treat keloid and hypertrophic scar surgically(2022)